Head-to-head
Hims & Hers vs Ivim Health
Hims & Hers and Ivim Health both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Hims & Hers
Higher scoreRanked #5 · Grade B
Best for: Working moms who want a recognizable, phone-native brand with a quick async signup and one clearly posted semaglutide number, and don't need tirzepatide pricing up front.
Visit Hims & HersIvim Health
Ranked #7 · Grade B
Best for: Working moms who'd trade a few days and a higher price for more clinician contact and structured titration support, not the leanest self-serve checkout.
Visit Ivim HealthThe verdict
Hims & Hers edges out Ivim Health on the Rx-Readiness Score, 86 to 84 (B vs B). Working moms who want a recognizable, phone-native brand with a quick async signup and one clearly posted semaglutide number, and don't need tirzepatide pricing up front.
Ivim Health is still a genuine option — the clinician-forward option: flat pricing on both molecules and a program built around provider check-ins. You pay up and wait a touch longer for a more supervised, hand-held start. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Hims & Hers | Ivim Health |
|---|---|---|
| Rx-Readiness Score | 86/100 · B | 84/100 · B |
| Overall rank | #5 | #7 |
| Semaglutide | $199/mo | $249/mo |
| Tirzepatide | Not disclosed | $399/mo |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Hims & Hers
Ranked #5 · Grade B
What we like
- Slick, phone-native intake you can finish between meetings
- Flat, publicly posted semaglutide price — no dose-tier math
- Mature nationwide operator with a real support stack behind it
The caveats
- Tirzepatide pricing isn't consistently posted, so switching molecules is a question mark
- Compounded only, injection only
- The broader Hims/Hers catalog nudges upsells into a decision that should be one line long
Ivim Health
Ranked #7 · Grade B
What we like
- Flat monthly on both semaglutide and tirzepatide — predictable to budget
- Provider-led model with real check-ins for people who want a human in the loop
- Both molecules on one account, so a switch doesn't mean re-signing
The caveats
- Premium pricing versus the budget tiers
- More clinical touchpoints can slow the very first dose
- Coverage is multi-state, not a confirmed all-50 footprint
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Hims & Hers and Ivim Health against other providers on our shortlist.
- Hims & Hers vs CoreAge Rx
- Hims & Hers vs Eden
- Hims & Hers vs Trimi Health
- Ivim Health vs Zealthy
- Ivim Health vs Gala Health
- Ivim Health vs Noom Med
Or browse the full comparison hub.